Poster
Variability in Liver Biopsy Assessment: Data from the Pegozafermin Phase 1b/2a Study in Subjects with Non-Alcoholic Steatohepatitis (NASH)
AASLD 2022
Study Background
The objective of the study was to assess the impact on histological endpoints in the Phase 1b/2a POC study of assessment by 4 individual expert NASH pathologists.
Authors
Loomba et al.